GlassScriptPhysician profile
Ajay K Dubey
NPI 1548207509
$207.22
in general payments reported to CMS, 2019-2025
8 companies · $76.53 in 2025
The $76.53 reported for 2025 was less than what a typical Radiation Oncology provider received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $24.77 · 2021: $23.93 · 2022: $17.60 · 2024: $64.39 · 2025: $76.53.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $141.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $140.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Napo Pharmaceuticals INC | $34.98 | 2024 | Gelclair Concentrated Oral Gel |
| Pharmaessentia USA Corporation | $29.88 | 2025 | Besremi |
| Medtronic, INC. | $29.41 | 2024 | Osteocool Rf Ablation System |
| Bayer Healthcare Pharmaceuticals INC. | $24.77 | 2019 | |
| Myovant Sciences INC. | $23.93 | 2021 | |
| Daiichi Sankyo INC. | $23.81 | 2025 | Enhertu |
| Boston Scientific Corporation | $22.84 | 2025 | Spaceoar Vue System - 10ml |
| Novartis Pharmaceuticals Corporation | $17.60 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ajay Dubey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.